Evidence map›Paper›PMID 33615198›Full record

ArticleiScience2021

Tryptophan Metabolism Regulates Proliferative Capacity of Human Pluripotent Stem Cells.

Shota Someya, Shugo Tohyama, Kotaro Kameda, Sho Tanosaki, Yuika Morita, Kazunori Sasaki, Moon-Il Kang, Yoshikazu Kishino, Marina Okada, Hidenori Tani and 9 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Nutrient regulation of development and cell fate decisions.Development (Cambridge, England) · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Shota SomeyaDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Shugo TohyamaDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Kotaro KamedaDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Sho TanosakiDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Yuika MoritaDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Kazunori SasakiHuman Metabolome Technologies, Inc., Tsuruoka, Yamagata 997-0052, Japan.
Moon-Il KangHuman Metabolome Technologies, Inc., Tsuruoka, Yamagata 997-0052, Japan.
Yoshikazu KishinoDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Marina OkadaDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Hidenori TaniDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Yusuke SomaDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Kazuaki NakajimaDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Tomohiko UmeiDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Otoya SekineDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Taijun MoriwakiDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Hideaki KanazawaDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Eiji KobayashiDepartment of Organ Fabrication, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Jun FujitaDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Keiichi FukudaDepartment of Cardiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Keio University · JPNational Institute of Technology, Tsuruoka College · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human pluripotent stem cells (hPSCs) have a unique metabolic signature for maintenance of pluripotency, self-renewal, and survival. Although hPSCs could be potentially used in regenerative medicine, the prohibitive cost associated with large-scale cell culture presents a major barrier to the clinical application of hPSC. Moreover, without a fully characterized metabolic signature, hPSC culture conditions are not optimized. Here, we performed detailed amino acid profiling and found that tryptophan (TRP) plays a key role in the proliferation with maintenance of pluripotency. In addition, metabolome analyses revealed that intra- and extracellular kynurenine (KYN) is decreased under TRP-supplemented conditions, whereas N-formylkynurenine (NFK), the upstream metabolite of KYN, is increased thereby contributing to proliferation promotion. Taken together, we demonstrate that TRP is indispensable for survival and proliferation of hPSCs. A deeper understanding of TRP metabolism will enable cost-effective large-scale production of hPSCs, leading to advances in regenerative medicine.

Indexed as

Cell BiologyMetabolomicsStem Cell Research

Identifiers

PMID33615198
PMCPMC7878994
OpenAlexW3123928297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.